Nuvation Bio Inc.
NUVB
$4.32
-$0.40-8.48%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 83.23M | 41.87M | 13.12M | 4.83M | 3.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 83.23M | 41.87M | 13.12M | 4.83M | 3.08M |
| Cost of Revenue | 5.99M | 1.28M | 3.35M | 2.58M | 2.09M |
| Gross Profit | 77.24M | 40.59M | 9.77M | 2.26M | 990.00K |
| SG&A Expenses | 38.31M | 40.33M | 37.36M | 38.48M | 35.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 79.35M | 75.90M | 69.55M | 68.42M | 62.09M |
| Operating Income | 3.88M | -34.04M | -56.43M | -63.59M | -59.00M |
| Income Before Tax | 5.40M | -36.59M | -55.79M | -59.01M | -53.24M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.40M | -36.59M | -55.79M | -59.01M | -53.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.40M | -36.59M | -55.79M | -59.01M | -53.24M |
| EBIT | 3.88M | -34.04M | -56.43M | -63.59M | -59.00M |
| EBITDA | 4.42M | -33.50M | -55.90M | -63.23M | -58.69M |
| EPS Basic | 0.02 | -0.11 | -0.16 | -0.17 | -0.16 |
| Normalized Basic EPS | 0.01 | -0.07 | -0.10 | -0.11 | -0.10 |
| EPS Diluted | 0.02 | -0.11 | -0.16 | -0.17 | -0.16 |
| Normalized Diluted EPS | 0.01 | -0.07 | -0.10 | -0.11 | -0.10 |
| Average Basic Shares Outstanding | 347.33M | 344.34M | 342.39M | 340.75M | 338.61M |
| Average Diluted Shares Outstanding | 347.33M | 344.34M | 342.39M | 340.75M | 338.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |